Medical Properties Trust (MPW) PT Raised to $17.00 at Mitsubishi UFJ Financial Group

Share on StockTwits

Medical Properties Trust (NYSE:MPW) had its price objective hoisted by Mitsubishi UFJ Financial Group to $17.00 in a research report report published on Monday morning, The Fly reports. They currently have a neutral rating on the real estate investment trust’s stock.

A number of other research firms have also weighed in on MPW. Wells Fargo & Co raised Medical Properties Trust from an underperform rating to a market perform rating and lifted their target price for the company from $13.50 to $17.50 in a report on Tuesday, December 11th. ValuEngine raised Medical Properties Trust from a hold rating to a buy rating in a report on Saturday, November 10th. Zacks Investment Research raised Medical Properties Trust from a sell rating to a hold rating in a report on Wednesday, November 7th. JPMorgan Chase & Co. raised Medical Properties Trust from a neutral rating to an overweight rating in a report on Wednesday, December 19th. Finally, SunTrust Banks lowered Medical Properties Trust from a buy rating to a hold rating in a report on Tuesday, December 18th. Six investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Medical Properties Trust currently has an average rating of Hold and an average price target of $16.75.

MPW stock opened at $18.36 on Monday. The company has a quick ratio of 4.92, a current ratio of 5.22 and a debt-to-equity ratio of 0.89. The stock has a market cap of $6.73 billion, a price-to-earnings ratio of 13.40, a P/E/G ratio of 6.42 and a beta of 0.72. Medical Properties Trust has a twelve month low of $12.20 and a twelve month high of $18.56.

Medical Properties Trust (NYSE:MPW) last posted its earnings results on Thursday, February 7th. The real estate investment trust reported $0.31 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.31. The business had revenue of $180.60 million during the quarter, compared to analyst estimates of $179.68 million. Medical Properties Trust had a return on equity of 8.83% and a net margin of 129.59%. The company’s quarterly revenue was down 11.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.37 EPS. Sell-side analysts expect that Medical Properties Trust will post 1.44 EPS for the current fiscal year.

In other news, Director Michael G. Stewart sold 5,800 shares of the business’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $17.39, for a total transaction of $100,862.00. Following the completion of the transaction, the director now owns 225,239 shares of the company’s stock, valued at $3,916,906.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Edward K. Aldag, Jr. sold 43,065 shares of the business’s stock in a transaction dated Wednesday, November 28th. The stock was sold at an average price of $16.78, for a total value of $722,630.70. Following the transaction, the chief executive officer now directly owns 1,873,541 shares of the company’s stock, valued at approximately $31,438,017.98. The disclosure for this sale can be found here. Insiders have sold 116,865 shares of company stock valued at $2,024,153 in the last three months. 0.83% of the stock is owned by insiders.

Several hedge funds and other institutional investors have recently modified their holdings of the company. Oregon Public Employees Retirement Fund lifted its position in Medical Properties Trust by 1,508.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 2,317,289 shares of the real estate investment trust’s stock worth $144,000 after buying an additional 2,173,179 shares during the last quarter. Prudential Financial Inc. lifted its position in Medical Properties Trust by 174.1% in the 4th quarter. Prudential Financial Inc. now owns 3,291,582 shares of the real estate investment trust’s stock worth $52,928,000 after buying an additional 2,090,516 shares during the last quarter. FMR LLC lifted its position in Medical Properties Trust by 96.7% in the 3rd quarter. FMR LLC now owns 3,876,161 shares of the real estate investment trust’s stock worth $57,793,000 after buying an additional 1,905,961 shares during the last quarter. WINTON GROUP Ltd lifted its position in Medical Properties Trust by 911.6% in the 4th quarter. WINTON GROUP Ltd now owns 1,379,416 shares of the real estate investment trust’s stock worth $22,181,000 after buying an additional 1,243,051 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in Medical Properties Trust by 1,361.8% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,251,587 shares of the real estate investment trust’s stock worth $18,661,000 after buying an additional 1,165,970 shares during the last quarter. 76.61% of the stock is owned by institutional investors.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Recommended Story: How mutual funds make money

The Fly

Analyst Recommendations for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply